Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | FABP7 | O15540 | 2/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | MDM4 | O15151 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | CASP3 | P42574 | 2/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25657687 | 0.95 | KMT2A (0.48) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL20013095 | 0.93 | KMT2A (0.62) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL20013329 | 0.93 | KMT2A (0.62) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL22199575 | 0.93 | KMT2A (0.62) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL22199576 | 0.93 | KMT2A (0.62) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL23156981 | 0.90 | KMT2A (0.44) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL25658818 | 0.90 | KMT2A (0.44) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL25658800 | 0.90 | KMT2A (0.44) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL25658804 | 0.90 | KMT2A (0.44) | KMT2AFABP7FABP5EPHX2MDM4 | |
| SCHEMBL29855170 | 0.90 | KMT2A (0.61) | KMT2AFABP7FABP5EPHX2MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114729006-A | Cyclic peptide compounds having Kras inhibitory activity | 中外制药株式会社 | 2022-07-08 | — | — | CN | disclosed |